Hodgkin Lymphoma   

Questions discussed in this category



The current NCCN guideline version 2.2021 is a little confusing. On page HODG-2,  the clinical staging/risk classification did not include ESR, b...

NCCN recommends either ISRT with rituximab/chemotherapy or ISRT alone in this scenario.  What factors help your decision making?

There are conflicting reports of increased incidence of bleomycin-induced lung toxicity with G-CSF.

Would you still proceed to high-dose therapy and autologous SCT? Would you incorporate radiation pre- or post- transplant? Or offer additional salvag...

Would the site of disease relapse play a role in your decision (i.e. isolated lymph node recurrence versus failure at primary site of disease)?


Papers discussed in this category


Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-05-10

Int. J. Radiat. Oncol. Biol. Phys., 2012 Jun 05

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-11-10

Chest, 1997-03

J. Clin. Oncol.,

Clin Genitourin Cancer, 2017 Sep 04

Eur. Urol., 2020 Jan 01

Blood, 2019-05-16

Blood,

N. Engl. J. Med., 2015-04-23

J. Clin. Oncol., 2019 Sep 10

J Clin Oncol, 2017 Mar 14

Pediatric blood & cancer, 2017-04

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-08-20

J Clin Oncol, 2020 Apr 28

Blood, 2009-09-03